APO-Candesartan HCTZ 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet bottle

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

hydrochlorothiazide, Quantity: 12.5 mg; candesartan cilexetil, Quantity: 32 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Candesartan cilexetil,Hydrochlorothiazide

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: carmellose calcium; iron oxide yellow; magnesium stearate; lactose monohydrate; hyprolose; maize starch; triacetin

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

100

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

The treatment of hypertension. Treatment should not be initiated with this fixed dose combination.

Sommarju tal-prodott:

Visual Identification: Yellow, capsule shaped, scored biconvex tablets, engraved APO with Notch on one side and 32 bisect 12.5 on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2013-05-13